皮肤疾病中甲索酸的适用情况概述
Mădălina Mocanu1,2, Dorina Procopciuc2, Dragoș-Florin Gheucă-Solovăstru3
1Department of Dermatology, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.
Medicina (Kaunas, Lithuania)
|July 27, 2024
概括
甲托雷克萨特是一种有效的免疫抑制药物,用于治疗各种皮肤疾病. 这篇评论探讨了它在治疗比牛皮之外的炎症性,囊泡性和增殖性皮肤病方面的好处.
科学领域:
- 皮肤病学 皮肤病学
- 免疫抑制疗法 免疫抑制疗法
背景情况:
- 甲托雷克萨特已在皮肤病学中使用了50多年.
- 除了牛皮,还没有标准化的甲托雷克萨特处方协议.
- 它在自身免疫和增殖性皮肤疾病中的有效性是公认的.
研究的目的:
- 审查甲状腺素在皮肤病学中的指示和益处.
- 为了突出它的用途超出了牛皮治疗.
- 专注于炎症性,囊泡性和增殖性皮肤病.
主要方法:
- 在皮肤病学中使用甲状腺素的文献综述.
- 对用于治疗各种皮肤疾病的甲状腺素的研究进行分析.
- 综合关于有效性和安全性的证据.
主要成果:
- 甲托雷克萨特在各种皮肤病理中显示出显著的治疗价值.
- 证据支持其用于除了牛皮之外的疾病.
- 具体的指示和益处详细介绍了各种疾病类别.
结论:
- 甲甲酸是许多炎症性,囊泡性和增殖性皮肤疾病的有价值的治疗选择.
- 进一步的研究和标准化的协议可以优化其在皮肤病学中的使用.
- 它的应用范围远远超出了牛皮的已知治疗方法.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
149
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
149
Skin Diseases and Disorders
3.7K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
3.7K
Skin Cancer
4.0K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.0K
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
110
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
110
Changes in Skin Color: Clinical Perspectives
1.9K
The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
1.9K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
124
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
124


